Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-13

Clinical Trial Update: Predicting Effective Therapy in Pancreatic Cancer

View source ↗

Summary

A Memorial Sloan Kettering Cancer Center-led clinical trial aiming to predict effective therapies for pancreatic cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer, Pancreatic Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING